These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 21596374

  • 1. [Increase of PTH in post-menopausal osteoporosis].
    Cerdà D, Peris P, Monegal A, Albaladejo C, Martínez de Osaba MJ, Surís X, Guañabens N.
    Rev Clin Esp; 2011; 211(7):338-43. PubMed ID: 21596374
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L.
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [Abstract] [Full Text] [Related]

  • 3. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 4. Comparisons of serum sclerostin levels among patients with postmenopausal osteoporosis, primary hyperparathyroidism and osteomalacia.
    Kaji H, Imanishi Y, Sugimoto T, Seino S.
    Exp Clin Endocrinol Diabetes; 2011 Jul; 119(7):440-4. PubMed ID: 21667439
    [Abstract] [Full Text] [Related]

  • 5. Search for hidden secondary causes in postmenopausal women with osteoporosis.
    Cerdá Gabaroi D, Peris P, Monegal A, Albaladejo C, Martínez MA, Muxí A, Martínez de Osaba MJ, Surís X, Guañabens N.
    Menopause; 2010 Jul; 17(1):135-9. PubMed ID: 19593233
    [Abstract] [Full Text] [Related]

  • 6. Calciotropic hormones and bone markers in the elderly.
    Gallagher JC, Kinyamu HK, Fowler SE, Dawson-Hughes B, Dalsky GP, Sherman SS.
    J Bone Miner Res; 1998 Mar; 13(3):475-82. PubMed ID: 9525348
    [Abstract] [Full Text] [Related]

  • 7. [Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in Reykjavík area].
    Karlsson SL, Indridason OS, Franzson L, Sigurdsson G.
    Laeknabladid; 2005 Feb; 91(2):161-9. PubMed ID: 16155312
    [Abstract] [Full Text] [Related]

  • 8. Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity.
    Yamashita H, Noguchi S, Moriyama T, Takamatsu Y, Sadanaga K, Uchino S, Watanabe S, Ogawa T.
    Surgery; 2005 Apr; 137(4):419-25. PubMed ID: 15800489
    [Abstract] [Full Text] [Related]

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D status and hyperparathyroisism in postmenopausal osteoporotic patients in Cipto Mangunkusumo hospital Jakarta.
    Sarmidi S, Setiyohadi B, KW SA.
    Acta Med Indones; 2008 Apr; 40(2):69-73. PubMed ID: 18560026
    [Abstract] [Full Text] [Related]

  • 11. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago.
    Lundgren E, Hagström EG, Lundin J, Winnerbäck K, Roos J, Ljunghall S, Rastad J.
    World J Surg; 2002 Aug; 26(8):931-6. PubMed ID: 12045863
    [Abstract] [Full Text] [Related]

  • 12. Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance.
    Mann GB, Kang YC, Brand C, Ebeling PR, Miller JA.
    J Clin Oncol; 2009 Aug 01; 27(22):3605-10. PubMed ID: 19546403
    [Abstract] [Full Text] [Related]

  • 13. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
    Beyer TD, Solorzano CC, Prinz RA, Babu A, Nilubol N, Patel S.
    Surgery; 2007 Jun 01; 141(6):777-83. PubMed ID: 17560254
    [Abstract] [Full Text] [Related]

  • 14. Normocalcemic hyperparathyroidism in patients with osteoporosis.
    Monchik JM, Gorgun E.
    Surgery; 2004 Dec 01; 136(6):1242-6. PubMed ID: 15657582
    [Abstract] [Full Text] [Related]

  • 15. Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake.
    Adami S, Viapiana O, Gatti D, Idolazzi L, Rossini M.
    Bone; 2008 Feb 01; 42(2):267-70. PubMed ID: 18024243
    [Abstract] [Full Text] [Related]

  • 16. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
    Anderson JL, Vanwoerkom RC, Horne BD, Bair TL, May HT, Lappé DL, Muhlestein JB.
    Am Heart J; 2011 Aug 01; 162(2):331-339.e2. PubMed ID: 21835295
    [Abstract] [Full Text] [Related]

  • 17. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar 01; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.